Summit Therapeutics
SMMT
#2212
Rank
โ‚ฌ7.67 B
Marketcap
9,60ย โ‚ฌ
Share price
0.48%
Change (1 day)
-33.89%
Change (1 year)

EPS for Summit Therapeutics (SMMT)

EPS in 2026 (TTM): -0,93ย โ‚ฌ

According to Summit Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,97ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,32ย โ‚ฌ.

EPS history for Summit Therapeutics from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,93ย โ‚ฌ-29.55%
2025-1,32ย โ‚ฌ
2021-0,87ย โ‚ฌ26.32%
2020-0,69ย โ‚ฌ
2018-0,03948ย โ‚ฌ-84.63%
2017-0,26ย โ‚ฌ-40.59%
2016-0,43ย โ‚ฌ6.54%
2015-0,41ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
-2,39ย โ‚ฌ 145.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
12,61ย โ‚ฌ-1,395.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Coherus BioSciences
CHRS
-0,94ย โ‚ฌ-3.74%๐Ÿ‡บ๐Ÿ‡ธ USA